MedTrace Logo

Combination Treatment for Moderate to Severe Acne

NCT01206348 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 97

Last updated 2011-11-30

No results posted yet for this study

Summary

To determine if a combination of three currently approved acne products are safe and effective for the treatment of moderate to severe acne

Conditions

Interventions

DRUG

Minocycline, Clindamycin, Tretinoin, Benzoyl Peroxide

Solodyn 1 tablet, Q day Ziana Gel, topical Q am Triaz FC, topical Q night

Sponsors & Collaborators

  • Medicis Global Service Corporation

    lead INDUSTRY

Principal Investigators

  • Mary Sanstead, BSN, CCRP · Medicis Global Service Corporation

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
12 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-09-30
Primary Completion
2011-07-31
Completion
2011-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01206348 on ClinicalTrials.gov